Osteopontin modulates angiotensin II- induced fibrosis in the intact murine heart  by Collins, Alan R et al.
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OBJECTIVES Osteopontin (OPN) is upregulated in left ventricular hypertrophy and is stimulated by
angiotensin II (AngII). Our objective was to determine whether mice deficient in OPN would
be protected from AngII-induced cardiac fibrosis.
BACKGROUND Interstitial fibrosis can lead to myocardial dysfunction and ultimately heart failure. Osteopon-
tin activates integrins that regulate cell adhesion, migration, and growth, thus implicating
OPN in the process of cardiac fibrosis.
METHODS Osteopontin null (OPN/) mice (n  18) and wild-type controls (n  20) were infused
with AngII (2.5 or 3.0 g/kg/min) for four days or three weeks via osmotic mini-pumps.
Hearts were assessed morphometrically and histologically, including quantitative assessment
of fibrosis via optical microscopic imaging analysis. Cardiac fibroblasts derived from these
mice were evaluated for adhesion and proliferation. Cardiac transcript expression for
cytokines, extracellular matrix (ECM), integrin, and atrial natriuretic peptide were assessed.
RESULTS Osteopontin/ mice exhibited less cardiac fibrosis (0.7%) than wild-type mice (8.0%) (p 
0.01) and lowered heart/body weight ratios (0.10% vs. 0.23%) (p  0.01) after three weeks
of AngII infusion. Expression of transforming growth factor-beta, fibronectin, and collagen
was not different between OPN/ and wild-type mice, despite the decrease in ECM
accumulation in the OPN/ mice. Adhesion to ECM substrates decreased by 30% to 50%
in cardiac fibroblasts of OPN/ mice but was restored in OPN/ cells by the addition of
recombinant osteopontin.
CONCLUSIONS Osteopontin mediates cardiac fibrosis, probably through the modulation of cellular adhesion
and proliferation. Because OPN is increased in cardiac hypertrophy and its lack attenuates
fibrosis, understanding of OPN function is essential to extend our knowledge about molecular
determinants of cardiac hypertrophy and failure. (J Am Coll Cardiol 2004;43:1698–705)
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(ardiac hypertrophy involves an increase in myocyte volume
ssociated with a disproportionate increase in the volume of
nterstitial fibroblasts and extracellular matrix relative to that
f myocytes (1). Little is known about fibroblast changes
hat occur during cardiac hypertrophy, but progressive
brosis impairs myocyte contractility, oxygenation, and
etabolism, thus contributing to ventricular dysfunction
nd perhaps ultimately heart failure (1,2). Osteopontin
OPN) is a large-acid phosphoprotein adhesion molecule
hat is secreted by both cardiac interstitial fibroblasts and
yocytes (3–5) and is upregulated in left ventricular hyper-
rophy (LVH) and failure in humans and animal models
4–6). Osteopontin contains the arginine-glycine-aspartate
ripeptide integrin binding motif and, by acting as an
ntegrin ligand, OPN can activate cell signaling pathways
nd gene expression and thereby regulate cell differentiation
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Manuscript received June 26, 2003; revised manuscript received November 13,p003, accepted November 14, 2003.nd function (2,6). We found that OPN expression in the
eart is potently regulated by angiotensin II (AngII) and
hat OPN is an important factor controlling cardiac fibro-
last growth, adhesion to extracellular matrix, and collagen
el contraction (4). Therefore, we hypothesized that OPN
ay be an important cardiac profibrotic factor. The avail-
bility of mice with targeted disruption of the Sppl gene that
ncodes osteopontin null (OPN/) mice allowed us to test
his hypothesis and to elucidate mechanisms involved in
ardiac fibrosis (7).
ETHODS
rotocol. Osteopontin knockout mice on a Black Swiss
ackground breeding pairs were the generous gift of R.
ohnson and C. Giachelli with the permission of L. Liaw
7). Osteopontin/ littermate controls were used through-
ut the study. For AngII stimulation, adult mice weighing
8 to 22 g were anesthetized with isoflurane. Osmotic
ini-pumps (Alza Corp., Palo Alto, California) containing
ither AngII (2.5 or 3 g/kg/min) in phosphate-buffered
aline (PBS), or PBS vehicle alone, were implanted subcu-
aneously for either four days (acute) or three weeks
chronic).
Blood pressure (BP) was measured by indirect tail cuff
lethysmography (Visitech Systems, Apex, North Caro-
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May 5, 2004:1698–705 Osteopontin and Cardiac Fibrosisina). At least 10 measurements were obtained at each time
oint and the mean and standard deviation were recorded.
nimals were habituated to the apparatus by BP measure-
ent during the week before initiation of the experimental
rotocol. Blood pressures were obtained daily until a plateau
evel was attained (four days) and then weekly for the
uration of the study.
After sacrifice by pentobarbital overdose and removal of
he osmotic mini-pump, the animal was weighed. The heart
as next removed, weighed, and was either snap frozen in
iquid nitrogen and maintained at 70°C or prepared for
istologic analysis.
uantification of interstitial fibrosis. Coronal sections of
he heart were made at the equator of the ventricles and the
issue fixed in 10% paraformaldehyde in PBS. Paraffin
ections (4 m) were used for Mallory’s trichrome staining.
uantification of interstitial fibrosis was performed using
igital microscopic analysis. The microscopic image was
isplayed on a high-resolution monitor and digitized by a
ideo frame grabber (PCVISION Plus, Imaging Technol-
gy, St. Laurent, Quebec, Canada) running on an IBM-
ompatible computer. A morphometric analysis program
Image Pro, Media Cybernetics, Silver Spring, Maryland)
as used to determine the area of fibrosis, defined as the
rea of blue trichrome stained fibers relative to the entire
pecimen. Contiguous high-power fields comprising an
ntire LV section for each sample were analyzed.
nalysis of gene expression from heart tissue. Total
ibonucleic acid was isolated from tissue using the single-step
cid guanidinium thiocyanate-phenol-chloroform extraction
ethod of Chomczynski and Sacchi (8) as modified by
ibco-BRL using Trizol reagent (Gibco-BRL, Rockville,
aryland). Ribonucleic acid was size fractionated by electro-
horesis through a denaturing agarose gel and transferred to
itrocellulose. [32P]-dCTP–labeled c-deoxyribonucleic acid
robe was then allowed to hybridize to the Northern blot.
ybridization signals were normalized to signal obtained from
ricetulus griscus ribosomal protein S2 (clone CHO-B Gene
ank accession number L22552), a constitutively expressed
ene, to correct for any variation in loading and transfer.
Abbreviations and Acronyms
AngII  angiotensin II
ANP  atrial natriuretic protein
BP  blood pressure
BrdU  bromodeoxyuridine
CARP  cardiac ankyrin repeat protein
ECM  extracellular matrix
LVH  left ventricular hypertrophy
OPN  osteopontin
OPN/  osteopontin null
PBS  phosphate-buffered saline
RNA  ribonucleic acid
TGF  transforming growth factor
WT  wild typeuantification of Northern blots was performed using a Dcanner with densitometric software (Scion Image, Frederick,
aryland). The complementary deoxyribonucleic acid probes
or known markers of cardiac hypertrophy including cardiac
nkyrin repeat protein (CARP), atrial natriuretic peptide
ANP), and OPN were used, as well as probes for the
rofibrotic factor, transforming growth factor (TGF)-beta, the
CM protein genes fibronectin and collagen I, and beta1
ntegrin.
ardiac fibroblast cell culture and treatment. Murine
ardiac fibroblast cultures were prepared from neonatal
PN/ and WT mouse pup hearts (4). In brief, one- to
our-day-old mouse pup hearts were washed, minced, and
ubjected to digestion with 4 g/ml collagenase type II
Worthington, Lakewood, New Jersey) and 2 g/ml dispase
Boehringer-Mannheim, Indianapolis, Indiana). After 20 to
0 min incubation at 37°C, the supernatant was collected,
nd undigested tissue was subjected to a second incubation
n the digestive cocktail. After three rounds of incubation,
he cells from the three collected supernatants were pooled,
ashed, and preplated for 60 min in DMEM/F12 supple-
ented with 5% fetal bovine serum. The adherent fibro-
lasts were then grown until confluent in DMEM/F12
upplemented with 10% fetal bovine serum. The cells were
assaged at 4 105 cells/10-cm plate and experiments were
erformed in the first or second passage after starvation in
erum-free DMEM/F12 media supplemented with insulin
5 g/ml), transferrin (5 g/ml), and selenium (5 ng/ml)
ITS, Sigma, St. Louis, Missouri).
dhesion and proliferation assays. Adhesion was mea-
ured to a variety of matrices including collagen I, fibronec-
in, laminin, and vitronectin at concentrations of 10 g/ml.
fter 18 to 24 h of serum starvation, fibroblasts were treated
ith 20% fetal calf serum or left untreated. After a further
8 h incubation the cells were trypsinized, washed, and
ounted. They were then seeded at 10,000 cells/well in a
6-well plate that had been coated with test substrate and
hen blocked with BSA. After a 1-h incubation at 37°C the
ells were washed and adherent cells were quantified by
xation and staining with toluidine blue, followed by
etermination of optical density at 595 nm. Bovine collagen
(Sigma), murine fibronectin (Calbiochem, La Jolla, Cali-
ornia), murine laminin (Gibco BRL), and rat vitronectin
Sigma) were each used at 10 g/ml in PBS for 1 h at room
emperature.
Proliferation was measured by bromodeoxyuridine
BrdU) incorporation using florescent activated cell sorting.
fter 18 to 24 h of serum starvation, fibroblasts were treated
ith 20% fetal calf serum or left untreated. After a further
0-h incubation, BrdU was added to a final concentration of
0 mM and the incubation continued for an additional 2 h.
ibroblast proliferation rates were determined by analyzing
ncorporation of BrdU by flow cytometry with Fast Immune
nti-BrdU with Dnase (Becton Dickinson, Franklin Lakes,
ew Jersey) according to the manufacturer’s directions.
ata were analyzed with Facscan software.
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Osteopontin and Cardiac Fibrosis May 5, 2004:1698–705tatistical analysis. Differences among means in BP and
nterstitial fibrosis between groups were performed using
nalysis of variance with the Student-Newman-Keuls test
or differences among means. Data are presented as means
SEM.
ESULTS
lood pressure and markers of cardiac hypertrophy.
ice lacking OPN expression had lower baseline BP (101
2 mm Hg, n  18) compared to WT mice (116  7 mm
g, n  20) (p  0.05) (Fig. 1A). AngII infusion at 2.5
g/kg/min effected similar changes from baseline BPs in
oth groups (55 mm Hg for WT and 48 mm Hg for
PN/ mice (Fig. 1B). Despite the similar rise in BP,
PN/ had lower absolute final BP (147  3 mm Hg, n
18) versus WT (171  10 mm Hg, n  20) (p  0.05)
Fig. 1A). To confirm that our subsequent results were not
elated simply to this absolute BP difference, a separate
/
igure 1. Blood pressures at baseline and after three weeks of angiotensin
I (AngII) infusion in wild-type (WT) and osteopontin-null (OPN/)
ice. Basal blood pressure (BP) is lower in OPN/ mice versus WT mice
p  0.01). Systolic blood pressure (SBP) of each group increased
ignificantly versus untreated mice (*p  0.05 WT; †p  0.05 OPN/)
hen infused with AngII at 2.5 g/kg/min. Infusion of AngII at 3
g/kg/min increased BP in OPN/ mice versus OPN/ basal values,
nd to a higher absolute systolic pressure versus either WT or OPN/
ice infused at the lower 2.5 g/kg/min dosing. 2.5 AngII  AngII at 2.5
g/kg/min; 3 AngII  AngII at 3 g/kg/min. Mean change in SBP of
T and OPN/ mice from sham-infused and after three weeks’
reatment with AngII at 2.5 g/kg/min was identical. The SBP in
PN/ mice treated with AngII at 3 g/kg/min was significantly higher
han in OPN/ mice or WT mice treated with AngII at 2.5 g/kg/min
p  0.001 vs. 2.5 g/kg/min AngII-infused WT or OPN/ mice).roup of OPN animals (n  10) were infused with a eigher dose of AngII for 3 weeks (3 g/kg/min), which
ncreased BP to 185  4 mm Hg, an absolute level even
igher than the WT animals attained at the lower AngII
ose, and one that produced a statistically increased change
n BP from basal values, vs. the other two groups (Figs. 1A
nd 1B).
Heart morphometry was assessed in the mice after vehicle
r AngII infusion. Despite lower basal BPs, OPN/ mice
n  18) had similar baseline heart/body weight ratio
ompared to WT (n  20) (Fig. 2). Although AngII-
ediated increases in BP were similar, the OPN/ mice
ad a blunted hypertrophic response versus WT even when
osing was increased to 3.0 g/kg/min, an infusion dose
hat caused an absolute BP level above that of WT infused
ice.
To assess for early molecular changes during AngII-
ediated stimulation, Northern blot analyses were per-
ormed at four days after initiation of infusion (when similar
ifferences from basal pressure were detected between
roups). We demonstrated an upregulation of both cardiac
nkyrin repeat protein (CARP) and ANP (Fig. 3A), known
arkers of the ventricular hypertrophic response.
After three weeks of AngII infusion CARP expression
eturned to basal levels while ANP remained modestly
levated (Fig. 3B). Osteopontin expression was barely de-
ected in sham-infused WT mice, but was markedly up-
egulated in WT mice after four days of AngII infusion.
fter three weeks of AngII infusion, OPN expression
ecreased in WT mice (Fig. 3C). No OPN was detected in
earts of OPN/ mice before or after AngII infusion (data
ot shown). These results suggest that AngII-mediated
tress modulates cardiac OPN expression, a response nec-
/
igure 2. Heart weight/body weight indices of WT and OPN/ mice at
aseline and after three weeks of AngII infusion. Angiotensin II causes
ypertrophy as detected by increased heart/body weight ratio in control but
ot in OPN/ mice. Heart-to-body-weight ratio of WT is significantly
ncreased in the AngII-treated group compared with the control sham-
nfused group (*p  0.001), whereas heart-to-body-weight ratio is not
ignificantly increased in either of the treated OPN/ groups, even when
g/kg/min AngII infusion affected BPs greater in both absolute value
nd percent change versus baseline compared with WT control animals.
hite bars  control; hatched bars  AngII, 2.5 g/kg/min; black bars
3 g/kg/min. Abbreviations as in Figure 1.ssarily absent in OPN animals.
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May 5, 2004:1698–705 Osteopontin and Cardiac Fibrosisack of OPN expression attenuates cardiac fibrosis.
ecause AngII infusion can modulate cardiac morphology,
e compared the morphometry of OPN/ and WT mice
Fig. 4). At baseline, no histologic differences were detected.
fter three weeks of AngII infusion, OPN/ mice had
inimal interstitial fibrosis as evidenced by Mallory’s
richrome staining, whereas WT mice had marked intersti-
ial fibrosis. On the basis of quantitative image analyses, the
T mice demonstrated a 10-fold (0.7  0.1% to 7.6 
.8%, n  12) increase in interstitial fibrosis in response to
ngII as compared to a more modest four-fold (0.4 0.2%
o 1.6 0.7%) response in the OPN/ mice, whether they
ere infused at 2.5 (n 15) or 3 (n 8) g/kg/min AngII.
To evaluate for potential etiologies of this difference in
he AngII-stimulated fibrotic response, we evaluated extra-
ellular matrix and cytokine expression in the mice. As
hown in Figure 5, transcripts for fibronectin, collagen I,
eta-1 integrin, and the profibrotic cytokine TGF-beta
ncreased to a similar extent in AngII-infused WT and
PN/ hearts.
ardiac fibroblast adhesion and growth. Another poten-
ial etiology for the altered fibrotic response of the OPN/
ice may be altered cell adhesion or proliferation. Thus, we
igure 3. Cardiac ankyrin repeat protein (CARP), atrial natriuretic factor
ngII infusion. (A) Ventricular CARP and ANF expression are upregulat
nfusion. (B) Ventricular CARP returns to baseline but ANF remains upr
PN/ groups. (C) Ventricular OPN messenger ribonucleic acid expressio
eeks post-infusion. Other abbreviations as in Figure 1.ext evaluated for an alteration in adhesive capabilities of ibroblasts derived from the OPN/ and WT mice.
ardiac fibroblast adhesion to a variety of ECM proteins
ncluding collagen I, fibronectin, laminin, and vitronectin
as decreased in cells from OPN/ mice compared to WT
Fig. 6). Overall, adhesion was decreased by 30% to 50% in
PN/ cells compared to the OPN/ fibroblasts. When
PN/ fibroblasts were grown in the presence of recom-
inant OPN, adhesion was nearly restored to that of the
T controls (Fig. 6). These data show an important role of
PN/ in cardiac fibroblast adhesion to ECM.
The BrDU incorporation was used to assess the prolifer-
tive responses of OPN/ as compared to WT fibroblasts.
erum-stimulated growth was blunted in cardiac fibroblasts
rom OPN/ compared to WT-derived fibroblasts (Fig.
). Addition of recombinant OPN only partly restored the
rowth responses of OPN/ fibroblasts to that of WT
ells.
ISCUSSION
he present investigation demonstrates that OPN is a
ritical factor in the development of AngII-mediated car-
iac fibrosis. Although AngII infusion resulted in similar
F) and OPN are molecular markers of cardiac hypertrophy increase after
both WT and OPN/ groups after four days of AngII (2.5 g/kg/min)
ed after three weeks of AngII (2.5 g/kg/min) infusion in both WT and
WT mice at four days after AngII infusion returns toward baseline by three(AN
ed in
egulat
n inncreases in systolic BP and in ventricular markers of
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Osteopontin and Cardiac Fibrosis May 5, 2004:1698–705ypertrophy, OPN/ mice demonstrated less increase in
eart weight/ body weight ratio and four-fold less intersti-
ial fibrosis than their WT counterparts. These histopatho-
ogic changes were associated with equivalent increases in
GF-beta, fibronectin, collagen I, and beta-1 integrin
xpression in WT and OPN/ hearts, suggesting similar
ncreases in ECM production. However, cardiac fibroblasts
rom neonatal OPN/ mice demonstrated less prolifera-
ive responses and reduced adhesion to a variety of extra-
ellular matrices, including collagen, fibronectin, laminin,
nd vitronectin compared to cells from neonatal WT mice.
hus, OPN appears to participate in growth and adhesion
igure 4. Absence of OPN leads to lessened myocardial fibrosis after
ild-type mice demonstrated a 10-fold increase in interstitial fibrosis (blue
 12, p  0.01) as compared to a more modest four-fold response in the
ith 2.5 g/kg/min (n  15) or 3 g/kg/min AngII (n  8), a dose that
he WT animals. (A) WT after three weeks of sham infusion; (B) WT after
f AngII infusion at 2.5 g/kg/min; (D) OPN/ after three weeks of Ang
ia analysis of digitized image of 20 magnified trichrome-stained section,
as significantly increased in the treated WT group but was not increased in
etween any of the sham-infused groups. White bars  control; hatched
igure 1.f cardiac fibroblast cells. Moreover, addition of recombi- mant OPN restored the adhesive properties of OPN/
ardiac fibroblasts. There is a trend, but the difference was
ot statistically significant for recombinant OPN to restore
rowth in OPN/ cells. Because an important mechanism
y which OPN affects these functions is through activation
f cell surface integrins, controlled interference with inte-
rin activation may be one approach to reduce cardiac
brosis and potentially prevent deterioration of ventricular
erformance in the face of deleterious hypertrophic stimuli.
Tissue remodeling in the heart is analogous to the wound
ealing response, with production of extracellular matrix,
ealignment of cells, and a restoration of normal amounts of
infusion. Trichrome stained myocardial sections demonstrate fibrosis.
ing) in response to AngII (2.5 g/kg/min) (0.7  0.16% to 8.0  1.37%;
/ (four-fold increase, 0.4  2.4% to 1.6  0.73%) mice whether infused
d a greater absolute BP and change from baseline than that measured in
weeks of AngII infusion at 2.5 g/kg/min; (C) OPN/ after three weeks
usion at 3 g/kg/min; (E) Quantitation of interstitial fibrosis, determined
ssed as percent of total myocardial cross-sectional area. Interstitial fibrosis
reated OPN/ groups (p 0.001). No significant difference was detected
AngII, 2.5 g/kg/min; black bars  3 g/kg/min. Abbreviations as inAngII
stain
OPN
cause
three
II inf
expre
the t
bars atrix by enzymatic degradation by matrix metalloprotein-
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May 5, 2004:1698–705 Osteopontin and Cardiac Fibrosisses. Fibrosis results from excess accumulation of ECM.
ngiotensin II can promote abnormal remodeling in car-
iovascular and renal tissues because it promotes increased
CM production with a decrease in ECM degradation
1,5,9). In the heart AngII has multiple profibrotic actions:
t stimulates cardiac fibroblast growth; increases expression
f TGF-beta, a cytokine-stimulating collagen, and other
CM protein production; and increases several factors
egulating cardiac fibroblast adhesion to ECM, including
PN and integrins (10,11). These effects are mediated by
he AngII type 1 receptor (4,10,12,13), whereas the AngII
ype 2 receptor has been implicated in the inhibition of
ardiac fibrosis (14,15) and mortality after experimental
yocardial infarction in mice (16) and is upregulated in
ailing human hearts (17). Interestingly, the AT2 receptor
as been detected on the cardiac fibroblast in humans (17)
ut has not been detected on mouse cardiac fibroblasts (11).
AngII also enhances tissue accumulation of ECM (16).
hysiologic doses of AngII (1010M) stimulate OPN pro-
uction in both cardiac fibroblasts and in cardiac myocytes,
uggesting that OPN may mediate some of these endoge-
igure 5. Angiotensin II increases ventricular fibronectin (FN), collagen
imilarly in WT mice (A) versus OPN/ mice (B). Ribonucleic acid w
nfusion. Increases in all transcripts were detected after AngII infusion in
wo treated groups. CHO-B was used as a loading control. Abbreviationsous AngII effects (4,5). This conclusion is supported by the uresent study, in which genetic ablation of OPN attenuated
ardiac fibroblast growth and adhesion and ultimately
lowed the development of AngII-mediated cardiac inter-
titial fibrosis in vivo. These results suggest that though
ngII stimulates TGF-beta and fibronectin expression in
T and OPN/ mice, the decrease in cardiac fibroblast
rowth contributes to the decrease in fibrosis. These data
emonstrate that OPN affects critical mechanisms that
ncrease ECM accumulation and that OPN is an important
ardiac profibrotic factor.
The parallel changes in ventricular ANP, CARP, and
PN in WT mice also support our conclusion that in-
reased OPN expression is a molecular marker of LVH.
hen stressed, the myocyte response includes an increase in
NP production that limits myocyte and fibroblast growth,
n alteration in phospholamban expression that improves
ardiac contractility, and a change in the adult pattern of
ontractile protein gene expression to that of a fetal pattern
18–20). Indeed, in a variety of animal models of cardiac
ypertrophy (aortic banding, Goldblatt hypertension, and
he spontaneously hypertensive rat) and in humans, ventric-
nsforming growth factor-beta, and integrin beta-1 transcript expression
lated from ventricular samples at baseline or after three weeks of AngII
he WT and OPN/ mice, yet no differences were detected between the
Figure 1.I, tra
as iso
both tlar ANP expression correlated with OPN expression (4).
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Osteopontin and Cardiac Fibrosis May 5, 2004:1698–705he present study demonstrates that LVH in the mouse was
lso associated with upregulation of OPN expression, al-
hough unlike in the rat, expression was transient, as was the
ncreased ANP and CARP expression. We have shown that
oth the cardiomyocyte and fibroblast are sources of OPN
n the heart (5), but the effects of OPN on the myocyte are
nknown. The OPN production by the myocyte may be a
aracrine mechanism by which the myocyte communicates
ith neighboring fibroblasts to regulate their growth and
brotic responses (6). Blocking antibodies against OPN
nhibit rat cardiac fibroblast adhesion to matrix proteins,
nd thus growth, as adhesion is necessary for cell growth (4).
imilarly, cardiac fibroblasts communicate with myocytes
hrough expression and secretion of paracrine factors such as
igure 6. Adhesion of OPN/ cardiac fibroblasts to a panel of ECM
ubstrates is reduced versus WT cells and can be returned toward WT
evels with addition of recombinant OPN. The figure shows a comparison
f adhesion of neonatal cardiac fibroblasts from WT, untreated OPN/
ersus OPN/ cells grown in the presence of recombinant OPN
OPN/  recOPN) to a panel of ECM components, as indicated along
he x-axis (BSA  bovine serum albumin, COL  collagen I, FN 
bronectin, LN  laminin, and VN  vitronectin). Overall adhesion of
T-derived cells is greater than that of OPN/derived cells (*p 0.001
or all substrates). Growth of OPN-derived fibroblasts in the presence of
ecombinant OPN increased their adhesion towards normal WT values (p
0.01 for all substrates). White bars  wild-type (WT); hatched bars 
PN/; black bars  OPN/  recombinant OPN. BSA  bovine
erum albumin, COL  collagen I, FN  fibronectin, LN  laminin, and
N  vitronectin. Other abbreviations as in Figure 1.
igure 7. Proliferation of OPN/-derived fibroblasts is blunted versus
T cells. Osteopontin-null cells grown in the absence of exogenous OPN
ad a significantly reduced proliferative response to serum stimulation
ersus WT-derived cells, whereas OPN/ cells grown in the presence of
xogenous OPN had proliferative capacities not significantly different fromT values. *p  0.05 vs. WT. Abbreviations as in Figure 1.ndothelin, an important regulator of cardiomyocyte hyper-
rophic responses (21).
Despite the upregulation of CARP and ANP, OPN/
nimals have a tendency to develop less increase in heart
eight in response to AngII infusion compared to WT, in
hich the increase over sham infusion was significant. Even
t higher levels of AngII infusion (3 g/kg/min) with a
arked increase in BP compared to sham-infused, there
as only a tendency for an increase in heart weight that was
ot statistically significant. Whether this result was related
o the decreased fibrosis and possibly decreased myocyte
ypertrophy is unknown. Nevertheless, these observations
uggest that OPN not only is a marker of the hypertrophic
esponse to AngII and hypertension but also may mediate
he response.
In agreement with our study in the heart, OPN/ mice
emonstrate altered remodeling responses in other tissues.
or example, skin incision in OPN/ mice was associated
ith more cell debris, greater disorganization of matrix, and
maller collagen fibril diameter in the wound than in WT
ice (7). Osteopontin-null mice were also studied in a
odel of obstructive uropathy caused by ureteral ligation.
bstructive uropathy is associated with an increase in renal
PN expression, tubular atrophy, and increased interstitial
nflammation and fibrosis (22). The uropathic OPN/
ice had decreased renal macrophage levels, decreased
GF-beta expression, and less accumulation of collagens I
nd IV, resulting in less interstitial fibrosis compared to WT
idney (22). Likewise, after myocardial infarction, OPN/
ice had increased left ventricular dilation and reduced
ollagen content compared with WT mice (23). The WT
ice had a seven-fold increase in type I collagen in the
nfarcted region, whereas OPN/ mice had decreased
xpression of collagen I messenger ribonucleic acid and no
vident collagen accumulation at the infarct site (23).
Taken together, the present observations suggest that
PN may modulate the AngII-mediated fibrotic response
nd collagen accumulation in tissue injury, possibly as a
esult of alterations in cell proliferation and adhesion.
urther studies are necessary to determine whether modu-
ation of OPN is a beneficial strategy to control adverse
ardiac remodeling.
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